StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
3965.T$790.00-1.25%
Fair $790.00+0.0%

3965.T

Capital Asset Planning, Inc.

Technology / Software - ApplicationTokyo

$790.00

-10.00 (-1.25%)

Fairly Valued+0.0%Fair Value $790.00Fund rank 29/100 · Data gapFallback financials|
SA 48/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $328.5M · quality 51.3/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 26/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

48/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 3965.TLocal privado en este navegador · Capital Asset Planning, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.5B

P/E

8.4x

↓

EV/EBITDA

4.9x

↓

ROE

10.6%

↑

Gross Margin

21.9%

↓

Debt/Equity

0.37

↑
52-Week Range$790
$727$912

TradingView lightweight chart

3965.T price, volumen y niveles de valoración

Último $790.00Periodo -40.4%
Fair value: $790.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+12.8%

FCF CAGR

—

FCF margin

3.4%

FCF / Net income

0.82x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $9.69B · net income $401.8M · FCF $328.5M

2022-FY → 2025-FY

Gross margin

21.9%+7.3% pts

Operating margin

5.5%+9.3% pts

Net margin

4.1%+7.8% pts

FCF margin

3.4%+10.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$9.69B$9.69B$8.18B$8.05B$6.75B
Net Income$401.8M$401.8M$156.8M$221.6M$-248.4M
EBITDA$846.6M$846.6M$613.2M$761.8M$53.2M
EPS——27.3538.72-43.45
Gross Margin21.9%21.9%21.1%20.6%14.6%
Operating Margin5.5%5.5%3.6%4.0%-3.9%
Net Margin4.1%4.1%1.9%2.8%-3.7%
Balance Sheet
Debt/Equity0.370.370.440.420.47
Current Ratio2.042.04———
Cash Flow
Free Cash Flow$328.5M$328.5M$-429.5M$879.7M$-460.0M
Returns
ROE10.6%10.6%4.8%7.0%-8.5%
Valuation
P/E8.418.4127.3120.12—
EV/EBITDA4.944.947.035.1366.00
P/B1.201.201.301.421.14
Growth & Yield
Revenue Growth18.5%18.5%1.6%19.3%—
EPS Growth——-29.4%189.1%—
Dividend Yield2.6%2.6%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +7.3%

Total return

+7.3%

Start / end P/E

n/dx → n/dx

EPS bridge

27.35 → n/d

Residual

+4.6%

EPS growthn/d
Multiple reratingn/d
Dividend+2.6%
Residual / FX / buybacks / cross-term+4.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.